Urinary tract obstruction treatment devices are used to remove or break down kidney stones and treat different conditions related to urinary tract obstruction. Some key urinary tract obstruction treatment devices include ureteral stents, nephrostomy catheter, and ureterorenoscope. Ureteral stents are tube-like devices inserted into the ureter to prevent or treat obstruction of urine flow. Nephrostomy catheters are thin, flexible tubes inserted through the skin and into the kidney to drain urine or provide treatment. Ureterorenoscope allows physicians to directly visualize the interior of the ureter and kidney to detect and remove stones using basket extraction devices. The rising prevalence of kidney stones and increasing geriatric population are majorly driving the demand for urinary tract obstruction treatment devices.
The Global Urinary Tract Obstruction Treatment Devices Market is estimated to be valued at USD 1.41 billion in 2024 and is expected to reach USD 2.03 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.
Key Takeaways
Key players operating in the urinary tract obstruction treatment devices are Boston Scientific, Cook Medical, C. R. Bard, Olympus, Coloplast, B. Braun Melsungen, and Medtronic. Boston Scientific holds the major market share with its wide range of ureteral stents and kidney stone baskets.
The growing number of kidney stone cases globally is a key factor fueling the demand for Urinary Tract Obstruction Treatment Devices Market. According to the National Kidney Foundation, nearly 1 in 11 people will develop kidney stones in their lifetime.
Technological advancements in minimally invasive procedures have led to the emergence of digital flexible ureterorenoscopes and holmium laser lithotripters, enabling more effective stone removal. Miniaturization of ureteral stents and baskets allows treating more complex cases of kidney stones.
Market Trends
- Increasing preference for minimally invasive procedures - Advancements in digital flexible ureterorenoscopes and laser lithotripters have increased the adoption of minimally invasive procedures over open surgeries for treating kidney stones. This trend is expected to continue driving the market growth.
- Growing demand for disposable/single-use devices - Providers are showing inclination towards single-use ureteral stents and nephrostomy catheters to reduce the risk of infection. This has boosted the demand for disposable urinary tract obstruction treatment devices.
Market Opportunities
- Untapped potential in developing countries - Countries in Asia Pacific and Latin America offer lucrative opportunities for players, given the rising patient pool and improving healthcare outcomes. However, these regions are still underpenetrated.
- Development of combinational therapy devices - Increased focus on developing devices enabling combinational therapies, such as digital ureterorenoscopes integrated with lithotripters, presents significant opportunities.
COVID-19 Impact on Urinary Tract Obstruction Treatment Devices Market
The COVID-19 pandemic has significantly impacted the urinary tract obstruction treatment devices market. During the peak of the pandemic in 2020, most elective surgeries and non-essential medical procedures were postponed to avoid overburdening healthcare facilities and resources. This led to a significant decline in demand for urinary tract obstruction treatment devices as their use is largely dependent on the number of surgical procedures performed. Manufacturers also faced disruptions in their supply chains and production activities due to lockdowns.
As the pandemic situation has relatively improved in 2021 with rapid vaccination drives, the market is witnessing a strong recovery. However, device sales are still lower than the pre-pandemic levels as many delayed cases are yet to be handled. Most industry experts expect the demand to normalise back to the pre-COVID growth trend by late 2022 or 2023. Manufacturers are forming new strategies like investing in telehealth and digital platforms to sustain their business during such crises. They are also ensuring strict safety and hygiene protocols at all stages to regain patients' confidence in elective surgeries.
Geographically, North America dominates the urinary tract obstruction treatment devices market in terms of value, accounting for over 40% share. This is attributed to the region's highly developed healthcare infrastructure and rising geriatric population prone to urological conditions. With growing awareness about minimally invasive treatments, the adoption of urinary tract obstruction treatment devices is also high in Western European countries.
The Asia Pacific region has emerged as the fastest growing market for these devices in recent years. This rapid growth can be accredited to increasing healthcare expenditures, improving access to insurance coverage, and rising prevalence of urinary diseases due to lifestyle changes and aging trends in China, India, and other developing Asian nations. Moreover, growing medical tourism in Thailand, Singapore, and Malaysia is also contributing to the market growth in Asia Pacific.
Get more insight on : Urinary Tract Obstruction Treatment Devices Market
Get this Report in Japanese Language: 尿路閉塞治療機器市場
Get this Report in Korean Language: 요로폐쇄 치료 장치 시장
Explore more related articles – Global EYLEA Drug - A Breakthrough In Treatment Of Retinal Diseases
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)